Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · USD

$3.08

+0.12 (+4.0%)· Recorded snapshot

Market cap	597.1K
Revenue (ttm)	35.3M
Net income (ttm)	-5.8M
EPS (ttm)	-$164
Shares out	193.9K
Volume	214,205
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 35.3M
Net income (ttm): -5.8M
EPS (ttm): -$164
Market cap: 597.1K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-21.9

P25 -113.8P50 -46.5P75 -0.9

ROIC-11.9

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All SBFM indicators

Market & fundamental data

Available fields

213

Groups with data

Currency

USD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001402328
Company name	Sunshine Biopharma, Inc.
Country	United States
Country code	US
CUSIP number	867781809
Earnings date	2026-11-12
Earnings time	amc
Employees	50
Employees change	-2
Employees growth	-3.85%
Enterprise value	$-12.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US8677818093
Last 10-K release date	2026-04-03
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-10-26
Last stock split type	Reverse
Market cap	$597,107
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$3.08
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SBFM
U.S. state	Florida
Website	https://sunshinebiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-5,321.69%
FCF / EV yield	42.04%
FCF yield	-936.13%
Forward P/S	0.03x
Industry forward P/E	13.59x
Industry P/E	175.96x
P/B ratio	0.01x
P/S ratio	0.02x
Price / tangible book value	0.02x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-14.71%
EBITDA margin	-13.72%
Gross margin	30.3%
Operating margin	-14.71%
Pretax margin	-15.73%
Profit margin	-16.5%
Profit per employee	$-116,653
Revenue per employee	$706,935
ROA	-9.91%
ROA (5Y)	-32.15%
ROCE	-18.56%
ROE	-21.92%
ROIC	-11.85%
SBC / revenue	0.27%
Tax / revenue	0.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	4
Gross profit growth	-11.58%
Gross profit growth (Q)	-29.1%
Gross profit growth 3Y	26.12%
Gross profit growth 5Y	163.53%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-2.74%
Revenue growth (Q)	-1.56%
Revenue growth (QoQ)	14.53%
Revenue growth 3Y	34.5%
Revenue growth 5Y	203.13%
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-19,145
Depreciation and amortization	$349,667
EBIT	$-5.2M
EBITDA	$-4.8M
EPS	$-163.91
FCF per share	$-27.71
Financing cash flow	$8.5M
Free cash flow	$-5.4M
Free cash flow minus SBC	$-5.5M
Gross profit	$10.7M
Income taxes	$270,936
Investing cash flow	$-183,740
Net cash flow	$3.4M
Net income	$-5.8M
Operating cash flow minus SBC	$-5.4M
Operating income	$-5.2M
Revenue	$35.3M
Stock-based compensation	$96,900

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.18
Book value per share	$230.48
Debt / equity	0.02
Long-term assets	$3M
Long-term liabilities	$475,820
Net cash (debt)	$13.4M
Net cash / market cap	2,326.67%
Net cash growth	42.4%
Net debt / equity	-0.48
Piotroski F-Score	2
Property, plant and equipment	$1.1M
Shareholders' equity	$27.5M
Tangible book value	$25.7M
Tangible book value per share	$215.05
Total assets	$33.6M
Total cash	$14M
Total debt	$678,338
Total liabilities	$6.1M
WACC	5.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.08
Current assets	$30.7M
Current liabilities	$5.6M
Current ratio	5.46
Inventory turnover	1.96
Net working capital	$11.2M
Quick ratio	3.21
Working capital	$25M
Working capital turnover	1.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-186.54%
Dividend yield	0%
Shareholder yield	-186.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-100%
10Y return CAGR	-77.28%
10Y total return	-100%
150-day SMA	$70.59
15Y price change	-100%
15Y return CAGR	-72.61%
15Y total return	-100%
1D price change	4.05%
1M price change	-81.87%
1M total return	-81.87%
1W price change	-30.55%
1W total return	-30.55%
1Y price change	-99.22%
1Y return CAGR	-99.22%
1Y total return	-99.22%
20-day SMA	$6.30
200-day SMA	$111.48
3M price change	-90.01%
3M total return	-90.01%
3Y price change	-100%
3Y return CAGR	-97.12%
3Y total return	-100%
50-day SMA	$14.97
50-day SMA vs 200-day SMA	50under200
52-week high	$464.00
52-week high date	2026-05-18
52-week low	$2.58
52-week low date	2026-10-26
5Y price change	-100%
5Y return CAGR	-94.6%
5Y total return	-100%
6M price change	-98.44%
6M total return	-98.44%
All-time high	$2,416,666,666.67
All-time high date	2011-08-02
All-time low	$2.58
All-time low date	2026-10-26
Average true range (ATR)	$1.79
Average volume	868.1K
Beta (1Y)	1.11
Beta (2Y)	1.7
Beta (5Y)	1.35
Change from 52-week high	-99.34%
Change from 52-week low	19.38%
Change from all-time high	-100%
Change from all-time low	18.45%
Change from open	1.32%
Day's gap	2.7%
Dollar volume	$659,751
High price	$3.10
Low price	$2.89
Monthly RSI	39.31
Open price	$3.04
Position in 52-week range	90.48%
Premarket change	-1.69%
Premarket close	$2.96
Premarket price	$2.91
Premarket volume	76.9K
Previous close	$2.96
Price vs 150-day SMA	-95.67%
Price vs 20-day SMA	-51.49%
Price vs 200-day SMA	-97.26%
Price vs 50-day SMA	-79.58%
Relative volume	0.25
RSI	26.65
Sharpe ratio	-2.16
Sharpe ratio (3Y)	-1.52
Sharpe ratio (5Y)	-0.87
Sortino ratio	-3.14
Sortino ratio (3Y)	-2.18
Sortino ratio (5Y)	-1.48
Volume	214.2K
Weekly RSI	19.45
YTD price change	-98.76%
YTD total return	-98.76%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	145K
Float percentage	74.79%
Shares change (QoQ)	178.3%
Shares change (YoY)	186.54%
Shares held by insiders	1.76%
Shares held by institutions	26.75%
Shares outstanding	193.9K
Short % of float	90.68%
Short % of shares	67.82%
Short ratio	0.9 days

Deeper analysis on SBFM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SBFM report

Is a complete SBFM research report available?

No complete published report is available for Sunshine Biopharma, Inc. (SBFM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sunshine Biopharma, Inc. (SBFM)

Price

Financial snapshot

Fair-value bridge

Latest news · SBFM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SBFM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SBFM

Frequently asked questions